AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 80 filers reported holding AKERO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,780,607 | -0.9% | 1,419,150 | -8.5% | 1.92% | +11.6% |
| Q2 2023 | $72,404,704 | +30.1% | 1,550,754 | +6.6% | 1.72% | +29.7% |
| Q1 2023 | $55,639,758 | -27.5% | 1,454,254 | +3.8% | 1.33% | -28.1% |
| Q4 2022 | $76,755,839 | +64.5% | 1,400,654 | +2.2% | 1.85% | +53.3% |
| Q3 2022 | $46,648,000 | +626.5% | 1,369,973 | +101.6% | 1.20% | +544.4% |
| Q2 2022 | $6,421,000 | -28.8% | 679,514 | +7.0% | 0.19% | -17.6% |
| Q1 2022 | $9,014,000 | -27.4% | 635,214 | +8.2% | 0.23% | -20.9% |
| Q4 2021 | $12,417,000 | -2.3% | 587,101 | +3.2% | 0.29% | +7.5% |
| Q3 2021 | $12,710,000 | -3.1% | 568,701 | +7.6% | 0.27% | +3.1% |
| Q2 2021 | $13,115,000 | -13.3% | 528,601 | +1.4% | 0.26% | -21.5% |
| Q1 2021 | $15,119,000 | +13.7% | 521,171 | +1.1% | 0.33% | +17.0% |
| Q4 2020 | $13,297,000 | +2.1% | 515,371 | +21.8% | 0.28% | -14.5% |
| Q3 2020 | $13,025,000 | +115.1% | 423,040 | +74.1% | 0.33% | +98.8% |
| Q2 2020 | $6,055,000 | +26.9% | 242,985 | +8.0% | 0.17% | -15.7% |
| Q1 2020 | $4,770,000 | -4.5% | 225,000 | 0.0% | 0.20% | +24.7% |
| Q4 2019 | $4,994,000 | -2.4% | 225,000 | 0.0% | 0.16% | -22.5% |
| Q3 2019 | $5,119,000 | +18.8% | 225,000 | 0.0% | 0.20% | +30.8% |
| Q2 2019 | $4,309,000 | – | 225,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $179,296 | 57.03% |
| Redmile Group, LLC | 2,632,912 | $144,283,578 | 5.90% |
| Avidity Partners Management LP | 3,825,000 | $209,610,000 | 4.54% |
| COMMODORE CAPITAL LP | 537,076 | $29,432 | 4.44% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $32,564,955 | 3.92% |
| Paradigm Biocapital Advisors LP | 604,544 | $33,129,011 | 3.89% |
| Yiheng Capital Management, L.P. | 1,468,905 | $80,495,994 | 3.56% |
| Altium Capital Management LP | 125,000 | $6,850,000 | 3.48% |
| Tri Locum Partners LP | 128,851 | $7,061,000 | 2.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 172,100 | $9,431,080 | 2.70% |